Sonata® Sonography-Guided Transcervical Fibroid Ablation System 2.1
K-Number: K193516 · 2020-05-04
Device Summary
Frequently Asked Questions
What is the Sonata® Sonography-Guided Transcervical Fibroid Ablation System 2.1?
Sonata® Sonography-Guided Transcervical Fibroid Ablation System 2.1 is a medical device that received FDA 510(k) clearance on 2020-05-04. It is manufactured by Gynesonics, Inc.. The 510(k) number is K193516.
When was Sonata® Sonography-Guided Transcervical Fibroid Ablation System 2.1 approved by the FDA?
Sonata® Sonography-Guided Transcervical Fibroid Ablation System 2.1 received FDA 510(k) clearance on 2020-05-04, under approval number K193516.
What company makes Sonata® Sonography-Guided Transcervical Fibroid Ablation System 2.1?
Sonata® Sonography-Guided Transcervical Fibroid Ablation System 2.1 is manufactured by Gynesonics, Inc..
What is the FDA product code for Sonata® Sonography-Guided Transcervical Fibroid Ablation System 2.1?
The FDA product code for Sonata® Sonography-Guided Transcervical Fibroid Ablation System 2.1 is KNF.
Related Clinical Trials
Other Devices by Gynesonics, Inc.
Related Devices (Code: KNF)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.